NCT06657573
Vaccine Chatbot for Improving Influenza Vaccination Uptake
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Secondary (5)
Arms and interventions
In this arm, participants will receive a vaccine chatbot intervention for one and a half months. The AI-enabled influenza vaccine chatbot can be accessed online through WeChat or any web browsers, where people can ask any questions related to the influenza vaccine and get previously validated answers from the chatbot immediately. The chatbot is available for use at their convenience during the 1.5-month intervention, with invitations sent every ten days to reinforce the engagement.
The control group will not use the chatbot during the intervention duration.
Behavioral: An AI-enabled chatbot tailored for influenza vaccine consultation
Sites
1 site in 1 country
- Hangzhou Center for Disease Control and PreventionHangzhou, Zhejiang, China